Kymera Therapeutics GAAP EPS of -$0.88 misses by $0.11, revenue of $7.4M misses by $7.41M

Read more

Related Posts

WeRide Makes First European Fully Driverless Commercial Robobus Deployment in France with Beti, Renault, Macif

Entrée Announces Drill Results from Hugo North Extension and Heruga Deposits

WUSD Now Accepted at Iconic Metro Department Store Through dtcpay Integration

Kohler Wins Best of Show Booth Design at KBIS for Third Consecutive Year

ROHM Launches 650V GaN HEMT in a Compact, High-heat Dissipation TO-Leadless Package

American Lithium Reports Successful Resource Conversion with Significant Increase in Measured Resources at TLC, up 47% to 6.17 Mt contained LCE

Comments